Related Experiment Video

Updated: Aug 24, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

[New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia]

Patrizia Ferroni1, Stefania Basili, Giovanni Davì

  • 1Dipartimento di Medicina Sperimentale e Patologia, Università La Sapienza, Roma.

Recenti Progressi in Medicina
|May 18, 2004
PubMed

Insights

High cholesterol and atherosclerosis involve inflammation from platelets and monocytes. Statins may reduce cardiovascular risk by inhibiting inflammation and thrombosis.

Area of Science:

  • Cardiovascular Science
  • Inflammation Research
  • Atherosclerosis Pathogenesis

Background:

  • Hypercholesterolemia and atherosclerotic disorders are linked to low-grade inflammation involving artery wall and circulating cells.
  • Platelets and monocytes play key roles in atherogenesis via releasing bioactive substances.
  • Platelet inflammatory actions offer new insights into atherosclerosis mechanisms.

Purpose of the Study:

  • To explore the role of platelet-derived inflammatory mediators in hypercholesterolemia and atherosclerosis.
  • To understand how statins might mitigate atherosclerosis through anti-inflammatory and anti-thrombotic effects.

Main Methods:

  • Review of recent findings on platelet activation and cytokine synthesis.
  • Analysis of the link between inflammation, hypercholesterolemia, and plaque development.
  • Evaluation of evidence for statin-induced inhibition of inflammation and thrombosis.

Main Results:

  • Stimulated platelets synthesize proinflammatory cytokines implicated in hypercholesterolemia and plaque formation.
  • Platelet-derived inflammatory mediators contribute significantly to atherosclerotic processes.
  • Statins demonstrate interrelated inhibition of inflammation and thrombosis.

Conclusions:

  • Platelet inflammation is a critical factor in hypercholesterolemia and atherosclerosis.
  • Statins' clinical benefits may stem from their combined anti-inflammatory and anti-thrombotic actions.
  • Targeting platelet-mediated inflammation presents a potential therapeutic strategy for atherosclerosis.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...